» Authors » Francois Lang

Francois Lang

Explore the profile of Francois Lang including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 934
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Doua S, Germain N, Geandrot A, Defour C, Gay A, Massoubre C, et al.
J Proteomics . 2024 Dec; 312:105370. PMID: 39716569
Understanding biological mechanisms underlying anorexia nervosa (AN) is necessary to develop care strategies. Despite many articles dedicated to peptides assessment in AN, there is no systematic review. A scoping review...
2.
Galusca B, Gay A, Belleton G, Eisinger M, Massoubre C, Lang F, et al.
J Eat Disord . 2023 Sep; 11(1):172. PMID: 37773179
Background: In cases of Anorexia Nervosa (AN), achieving weight gain recovery beyond the lower limits set by the World Health Organization and normalizing classical nutritional markers appears to be essential...
3.
Charpentier M, Dupre E, Fortun A, Briand F, Maillasson M, Com E, et al.
Mol Oncol . 2021 Aug; 16(3):594-606. PMID: 34418284
The major challenge in antigen-specific immunotherapy of cancer is to select the most relevant tumor antigens to target. To this aim, understanding their mode of expression by tumor cells is...
4.
Dreno B, Khammari A, Fortun A, Vignard V, Saiagh S, Beauvais T, et al.
Cancer Immunol Immunother . 2021 Jun; 70(10):3015-3030. PMID: 34120214
Adoptive cell transfer (ACT) of tumor-specific T lymphocytes represents a relevant therapeutic strategy to treat metastatic melanoma patients. Ideal T-cells should combine tumor specificity and reactivity with survival in vivo,...
5.
Rabu C, Rangan L, Florenceau L, Fortun A, Charpentier M, Dupre E, et al.
Oncoimmunology . 2019 Mar; 8(4):e1560919. PMID: 30906653
There is now a consensus that efficient peptide vaccination against cancer requires that peptides should (i) be exclusively presented by professional APC and (ii) stimulate both CD4 and CD8-specific T...
6.
Simon S, Wu Z, Cruard J, Vignard V, Fortun A, Khammari A, et al.
Front Immunol . 2018 Sep; 9:1962. PMID: 30214446
Among Immunotherapeutic approaches for cancer treatment, the adoptive transfer of antigen specific T cells is still a relevant approach, that could have higher efficacy when further combined with immune check-point...
7.
Demner-Fushman D, Shooshan S, Rodriguez L, Aronson A, Lang F, Rogers W, et al.
Sci Data . 2018 Jan; 5:180001. PMID: 29381145
Adverse drug reactions (ADRs), unintended and sometimes dangerous effects that a drug may have, are one of the leading causes of morbidity and mortality during medical care. To date, there...
8.
Simon S, Vignard V, Varey E, Parrot T, Knol A, Khammari A, et al.
Cancer Res . 2017 Dec; 77(24):7083-7093. PMID: 29212853
Therapeutic strategies using anti-PD-1-blocking antibodies reported unparalleled effectiveness for melanoma immunotherapy, but deciphering immune responses modulated by anti-PD-1 treatment remains a crucial issue. Here, we analyzed the composition and functions...
9.
Estour B, Marouani N, Sigaud T, Lang F, Fakra E, Ling Y, et al.
Psychoneuroendocrinology . 2017 Jul; 84:94-100. PMID: 28692876
Introduction: Constitutional thinness (CT) is an underweight state characterized by normal menstruations and no change in feeding behaviour. Thinness is the only resemblance between Anorexia Nervosa (AN) and CT. Removal...
10.
Charpentier M, Croyal M, Carbonnelle D, Fortun A, Florenceau L, Rabu C, et al.
Oncotarget . 2016 Aug; 7(37):59704-59713. PMID: 27486971
MELOE-1 and MELOE-2, two highly specific melanoma antigens involved in T cell immunosurveillance are produced by IRES-dependent translation of the long « non coding » and polycistronic RNA, meloe. In...